发明名称 |
PHARMACEUTICAL COMPOSITIONS COMPRISING CLOPIDOGREL BESYLATE AND METHODS FOR PREPARING THE SAME |
摘要 |
A composition comprising clopidogrel besylate is provided to show high in vitro dissolution rate and have excellent stability without adding a separate additive such as an antioxidant by preparing the clopidogrel besylate in a solid dispersion with a copolymer of polyoxyethylene and polyoxypropylene and crospovidone as a disintegrant. A pharmaceutical composition comprises a clopidogrel besylate-containing solid dispersion prepared by dispersing 100 parts by weight of clopidogrel besylate, 3-15 parts by weight of a copolymer of polyoxyethylene and polyoxypropylene, 30-60 parts by weight of polyethyleneglycol and 5-20 parts by weight of crospovidone in 55-70 parts by weight of mannitol; and a pharmaceutically acceptable carrier such as a copolymer of polyoxyethylene and polyoxypropylene, crospovidone and a mixture thereof. A method for preparing the composition comprises the steps of: (a) dissolving clopidogrel besylate, a copolymer of polyoxyethylene and polyoxypropylene, polyethyleneglycol and crospovidone in 50-100% ethanol or an aqueous solution of ethanol; (b) dispersing the solution obtained from the step(a) in mannitol and then drying or spraying the solution of the step(a) with fluidizing the mannitol in a granulator to obtain a clopidogrel besylate-containing solid dispersion; and (c) mixing the clopidogrel besylate-containing solid dispersion with a pharmaceutically acceptable carrier. Further, the 0.2-0.4 wt.% of ethanol or an aqueous solution of ethanol is used based on the 100 wt.% of clopidogrel besylate.
|
申请公布号 |
KR100805675(B1) |
申请公布日期 |
2008.02.21 |
申请号 |
KR20070022408 |
申请日期 |
2007.03.07 |
申请人 |
HANLIM PHARMACEUTICAL CO., LTD. |
发明人 |
KIM, JAE SHIN;RYU, JONG HYEON;LEE, GEUN HYEOG;JEON, SE HWA;KIM, JIN SUN |
分类号 |
A61K31/4365;A61K9/14 |
主分类号 |
A61K31/4365 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|